The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
Reboot #159 Atrial Fibrillation
1 hour 23 minutes Posted Aug 9, 2021 at 7:00 am.
Intro, disclaimer and guest bio
Guest one liner, a bit on physician well-being and some other randomness
A case of palpitations; risk factors for atrial fibrillation
Subclinical atrial fibrillation, overdiagnosis of atrial fibrillation; How much afib burden matters?
Case summary and next steps in initial work up
Counseling patient about atrial fibrillation and its consequences
Ischemic heart disease and atrial fibrillation
Recap of diagnosis, initial work up and risk stratification in atrial fibrillation
Rate versus rhythm control; AFFIRM trial
Strict versus lenient rate control;  RACE trial
Deciding on rate versus rhythm control; Downside of antiarrhythmic therapies; When to switch from rate to rhythm control strategy
Ablation for atrial fibrillation; CASTLE-AF, CABANA trials
When to refer to cardiology and electrophysiology
Choice of agent for anticoagulation and latest guidelines for atrial fibrillation; New definition for valvular atrial fibrillation
DOACs in CKD and some other nuances in choice of agent
Bleeding and anticoagulation
Cardioversion for atrial fibrillation (initial versus delayed)
Anticoagulation before and after cardioversion
Lifestyles measures for atrial fibrillation
Atrial fibrillation during critical illness, after CABG and in hyperthyroidism
Aspirin monotherapy is not appropriate for atrial fibrillation
Take home points
Outro
0:00
1:23:18
Download MP3
Show notes
Enjoy this Curbsiders classic and stay tuned this Wednesday, August 11, 2021 for a brand new Afib Triple Distilled version.
Take control of atrial fibrillation with expert insights and pearls from cardiologist, Dr. James Furgerson, in this jam-packed episode! You’ll learn why atrial fibrillation is such a big deal, how to diagnose it, how to treat it and when to call in for reinforcements. Dr. James Furgerson, MD  is a cardiologist from San Antonio, Texas with over 20 years in academics. Buckle up – This episode is going to send your heart racing! You might even skip a beat! 
Episodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | thecurbsiders@gmail.com 
Credits
Writer and Producer: Cyrus Askin MD
Infographic: Cyrus Askin MD
Cover Art: Cyrus Askin MD
Hosts: Matthew Watto MD, Paul Williams MD, Cyrus Askin MD
Editors: Matthew Watto MD
Guest: James Furgerson MD
Sponsor: American College of Physicians acponline.org/100curb
ACP CME 100 virtual video package includes 100 hours of practice-changing updates by expert faculty from Internal Medicine Meeting 2021 acponline.org/100CURB. Plus enjoy an exclusive: 25 bonus CME sessions and access until June 1, 2024!
Sponsor: Panacea Financial panaceafinancial.com
Visit panaceafinancial.com today to open your account and join a bank built with you in mind. 
Time Stamps*
*Note: Time stamps refer to ad-free version 
00:00 Intro, disclaimer and guest bio
03:45 Guest one liner, a bit on physician well-being and some other randomness
08:15 A case of palpitations; risk factors for atrial fibrillation
12:17 Subclinical atrial fibrillation, overdiagnosis of atrial fibrillation; How much afib burden matters? 
15:08 Case summary and next steps in initial work up
18:48 Counseling patient about atrial fibrillation and its consequences
21:40 Ischemic heart disease and atrial fibrillation
24:17 Recap of diagnosis, initial work up and risk stratification in atrial fibrillation
25:25 Rate versus rhythm control; AFFIRM trial
30:50 Strict versus lenient rate control;  RACE trial
33:30 Deciding on rate versus rhythm control; Downside of antiarrhythmic therapies; When to switch from rate to rhythm control strategy
36:52 Ablation for atrial fibrillation; CASTLE-AF, CABANA trials
40:40 When to refer to cardiology and electrophysiology
42:42 Choice of agent for anticoagulation and latest guidelines for atrial fibrillation; New definition for valvular atrial fibrillation
45:22 DOACs in CKD and some other nuances in choice of agent
52:27 Bleeding and anticoagulation
58:38 Cardioversion for atrial fibrillation (initial versus delayed)
63:32 Anticoagulation before and after cardioversion
67:48 Lifestyles measures for atrial fibrillation
70:45 Atrial fibrillation during critical illness, after CABG and in hyperthyroidism
74:12 Aspirin monotherapy is not appropriate for atrial fibrillation
76:42 Take home points
78:50 Outro